Rakendu Shukla, 2020 graduateThe UC Davis Department of Radiation Oncology offers a four-year residency training program in clinical radiation oncology. The residency fulfills all requirements of the American Board of Radiology and is fully accredited by the American Medical Association's Accreditation Council for Graduate Medical Education (ACGME). Residents train at the UC Davis Comprehensive Cancer Center and the UC Davis Medical Center based in Sacramento, California. As the only NCI-designated comprehensive cancer center located in the Central Valley region encompassing Sacramento, the UC Davis Comprehensive Cancer Center serves a diverse, high-volume population of various socioeconomic and ethnic backgrounds and captures patients from a large portion of Northern California, Southern Oregon, and Western Nevada.

Our department is committed to creating a work environment where each person is treated with respect, courtesy, and sensitivity. In this regard, the department places an emphasis on adhering to the UC Davis Principles of Community. The UC Davis School of Medicine offers scholarships for underrepresented in medicine (URiM) students from other medical schools interested in an elective experience at one of our residency programs.

Fragoso
Ruben Fragoso, M.D., Ph.D.
Associate Professor
Program Director

The mission of the radiation oncology residency program is to train highly competent academic and private practice radiation oncologists in a multi-disciplinary, collegial setting. We aim to train physicians with broad, clinical expertise in all areas of radiation oncology, including external beam radiation, intracavitary and interstitial brachytherapy, SBRT, intracranial SRS, and transplant preparatory regimens such at total lymphoid and total body irradiation. Residents will undergo rigorous hands-on teaching, including high-volume brachytherapy and other special procedures, formal didactic instruction, with development of lifelong learning skills.

Residents will also gain significant exposure to radiation oncology research, including the design and execution of prospective clinical trials, patient accrual to cooperative group clinical trials, imaging, physics, and laboratory-based research, allowing interested residents to pursue careers as clinician investigators. The mission of UC Davis Health is to serve a diverse racial, ethnic, and socioeconomic community, from urban to rural communities, homeless and wealthy through superior patient care, research, and innovation.

Program Aims

  • Train highly educated residents with the required skill sets to succeed in the academic or private practice setting
  • Provide a culturally and economically diverse training environment, including rural and urban underserved.
  • Provide a strong academic and scholarly environment that enhances the quality of patient care

Program Overview

Residents are assigned to three-month clinical rotations during the course of training. In each rotation, residents practice under the supervision of one and in some cases two site-specific attending physicians in an apprenticeship-like format. These service-focused rotations foster one-on-one teaching and learning. Residents are an essential component of the practice team and work closely with ancillary staff and referring physicians to optimize care. Residents also obtain essential, practical training in physics/dosimetry/treatment during their rotations.

Our faculty of seven radiation oncologists, six medical physicists and three radiobiologists participate in the training and supervision of residents in the classroom, laboratory, and clinic. Residents attend and participate in numerous patient care-related conferences, tumor boards, presentations, and workshops on a weekly basis, typically accompanied by their assigned attending physician.

Clinical Core Didactic Curriculum

The clinical core didactic curriculum has consistently been rated by former and existing residents as one of the strengths of the training program. Lectures are organized into six to eight week didactic blocks focusing on a specific disease-site at a given time. Each of the clinical faculty members serve as moderators on a rotating basis depending on their area of expertise and are overwhelmingly committed to creating an interactive and educationally stimulating environment for trainees. Formal activities include instructional lectures, mock oral boards, case presentations, mortality and morbidity conferences and journal clubs. In 2011, the department began hosting the Cancer Center-wide "high impact" multidisciplinary journal club (held quarterly during lunch on the second Friday of each month) during which recently published literature pertaining to the specified disease site is reviewed with experts from other specialties. Additionally, the curriculum has been recently modified to include lectures on topics such as professionalism, bioethics, statistics, physician wellness, and health economics.

Richard Valicenti
Richard Valicenti, M.D.

Professor
Chair of Radiation Oncology

Megan Daly
Megan Daly, M.D.

Associate Professor

Ruben Fragoso
Ruben Fragoso, M.D., Ph.D.

Associate Professor
Medical Residency Director

Arta Monjazeb
Arta Monjazeb, M.D., Ph.D.

Associate Professor

Shyam Rao
Shyam Rao, M.D., Ph.D.

Associate Professor
Medical Director

Jason Zhao
Jason Zhao, M.D.

Assistant Professor

Current Residents

Michael Cardenas, M.D.
Chief Resident, PGY-5
Michael Cardenas, M.D.

Soheila Fayeghi Azghadi, M.D.
PGY-4
Soheila Fayeghi Azghadi, M.D.

Angel Morán, M.D.
PGY-4
Angel Morán, M.D.

Brittni Usera, M.D.
PGY-3
Brittni Usera, M.D.

Ahsen Ahmed, M.D., Ph.D.
PGY-2
Ahsen Ahmed, M.D., Ph.D.

Patrick Beagen, M.D.
PGY-2
Patrick Beagen, M.D.

Shera Feinstein, M.D.
PGY-2
Shera Feinstein, M.D.

Past Residents

Graduation Year Employer
2020 Adventist Health and Rideout Cancer Center, Marysville, CA
2020 WellStar Health System, Atlanta, GA
2019 University of Washington, Seattle, WA
2018 Peachtree Radiation Oncology, Atlanta, GA
2018 UC Davis Health, Dept. of Radiation Oncology, Sacramento, CA
2017 Centrecare Clinic Health Plaza, St. Cloud, MN
2016 Kessler Medical Center, Kessler AFB, Biloxi, MS
2016 Emory Winship Cancer Institute, Dept. of Radiation Oncology, Atlanta, GA
2016 Department of Radiation Oncology, Queen’s Medical Center Honolulu, Hawaii
2016 Coastal Radiation Oncology, Templeton, CA
2014 University of California, San Diego
2014 Salinas Valley Memorial Healthcare System, Salinas, CA
2013 South Baldwin Reginal Medical Center, Foley, AL
2012 Carle Foundation Hospital, Urbana, IL
2012 University of Arizona Health Sciences, Tucson, AZ
2010 Weill Cornell Medicine, Flushing, NY
2009 Mount Sinai Health, New York, NY

Publications / Oral and Poster Presentations / Book Chapters

Resident Scholarly Activities

Azghadi SF* and Morán A*, Maverakis E, Christensen SD, Monjazeb AM and Dyer BA. Combined PD-L1 Immune Checkpoint Blockade and Stereotactic Ablative Radiotherapy Induces Durable, Repeatable Systemic Abscopal Response. Cureus. 2019 Feb; 11(2): e4038. *Equally contributing authors.

McGee HM, Daly ME, Azghadi S, Stewart SL, Oesterich L, Schlom J, Donahue R, Schoenfeld JD, Chen Q, Rao S, Fragoso RC, Valicenti RK, Canter RJ, Maverakis EM, Murphy WJ, Kelly K, Monjazeb AM. Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site. Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1259-1270.

Ping Ng S, Dyer BA, Kalpathy-Cramer J, Mohamed ASR, Awan MJ, Gunn B, Phan J, Zafereo M, Debnam JM, Lewis CM, Colen RR, Kupferman ME, Guha-Thakurta N, Canahuate G, Marai GE, Vock D, Hamilton B, Holland J, Cardenas CE, Lai SY, Rosenthal DI, Fuller CD. A Prospective In Silico Analysis of Interdisciplinary and Interobserver Spatial Variability in Post-Operative Target Delineation of High-Risk Oral Cavity Cancers: Does Physician Specialty Matter? Clin Transl Radiat Oncol. 2018 Aug 2;12:40-46.

Zhang H and Hou K, Chen J, Dyer BA, Chen JC, Liu X, Zhang F, Rong Y, Qiu J. Fabrication of an Anthropomorphic Heterogeneous Mouse Phantom for Multimodality Medical Imaging. Phys Med Biol. 2018 Sep 28;63(19):195011.

Dyer BA, Zamarin D, Eskandar R, Mayadev JS. The Role of Immunotherapy in Management of Locally Advanced and Recurrent/Metastatic Cervical Cancer. J Natl Compr Canc Netw. 2019 Jan;17(1):91-97.

He Y* and Liu Y*, Dyer BA, Boone JM, Liu S, Chen T, Zheng F, Zhu Y, Sun Y, Rong Y, Qiu J. 3D printed breast phantom for multi-purpose and multi-modality imaging. Quant Imaging Med Surg. 2019 Jan;9(1):63-74. *Equally contributing authors.

Moran A, Azghadi S, Maverakis EM, Christensen S, Dyer BA. Combined Immune Checkpoint Blockade and Stereotactic Ablative Radiotherapy Can Stimulate Response to Immunotherapy in Metastatic Melanoma: A Case Report. Cureus. 2019 Feb 8;11(2):e4038.

Dyer BA*, Yuan Z*, Qiu J, Benedict SH, Valicenti RK, Mayadev JS, Rong Y. Factors associated with deformation accuracy and modes of failure for MRI-optimized cervical brachytherapy using deformable image registration. Brachytherapy. 2019 May-Jun;18(3):378-386. *Equally contributing authors.

He Y, Qin Y, Dyer BA, Zhang H, Zhao L, Chen T, Zheng F, Sun Y, Shi L, Rong Y, Qiu J. Polyvinyl chloride as a tissue-equivalent substitute in physical and mechanical properties for X-ray and magnetic resonance imaging. JACMP 2019.

Shukla RP, Nguyen KN, Dyer BA, Monjazeb AM. ASTRO/ARRO Pancreas SBRT Case Discussion. American Society for Radiation Oncology, 27 Dec 2018.

Nguyen KN, Shukla RP, Dyer BA. ASTRO/ARRO Image Challenge - Optic Nerve Sheath Meningioma. American Society for Radiation Oncology, 27 Dec 2018.

Nguyen KN, Shukla RP, Dyer BA, Rao SS. ASTRO/ARRO Esthesioneuroblastoma Case Discussion. American Society for Radiation Oncology, 8 Feb 2019.

Nguyen KNB, Hause DJ, Novak J, Monjazeb AM, Daly ME. Tumor Control and Toxicity after SBRT for Ultracentral, Central, and Paramediastinal Lung Tumors. Pract Radiat Oncol. 2019 Mar;9(2):e196-e202.

Shukla RP, Nguyen KN, Dyer BA. ASTRO/ARRO Image Challenge – Intraorbital Mass. American Society for Radiation Oncology, 18 Apr 2019.

Evangelista LM, Bayoumi A, Dyer BA, Shukla RP, Scott E, Rao SS, Belafsky PC. Risk Factors Associated with Radiation-Induced Trismus in Patients with Head and Neck Cancer. European Society for Swallowing Disorders (ESSD) European Congress. Dublin, Ireland September 24-29, 2018.

Evangelista LM, Bayoumi A, Dyer BA, Shukla RP, Rao SS, Belafsky PC. The Relationship Between Posterior Pharyngeal Wall Thickness and Swallowing Function After Radiation Therapy. The Fall Voice Conference. Seattle, WA 25-27 October 2018.

Shukla RP. Clinical Outcomes of Re-Irradiation with Stereotactic Body Radiation Therapy and Brachytherapy. UC Davis Re-Irradiation Conference. Sacramento, CA January 25, 2019.

Shukla RP. Radiation Biology Seminar with the Department of Gynecologic Oncology. Sacramento, CA March 2019

Stern R, Bernardez B, Harrell A, Wright C, Haney A, Dyer B, Shukla R, Rao S. Quality Improvement Project: Reducing Patient Wait Times using the DMAIC Methodologies. 9th UC Davis Health Quality Forum. Sacramento, CA March 2019

Application Process

To apply, you should first contact your medical school Dean’s office to access the Electronic Residency Application Service (ERAS) web-based application. The deadline for receipt of all application materials is December 30, 2020.

Match 2021: Two PGY-2 positions to begin July 1, 2022.

Required application materials include:

  • Common Application Form
  • Personal Statement
  • Medical School Transcripts
  • USMLE Scores
  • ECFGM Report (foreign medical graduates only)
  • Three Letters of Recommendation
  • Dean's Letter

Our program participates in the National Resident Match Program (NRMP). Upon selection as a resident candidate, you will receive an invitation along with an Interview Welcome Packet. Interview sessions will be held in November and December ahead of Match week, which occurs the third week of March.

Virtual Interview Days
The Department of Radiation Oncology will conduct virtual interviews on various dates and times between December 1, 2020 to February 26, 2021. More information will be posted to our website by October, 2020.


Important Information for Applicants

The links below will provide helpful information for candidates to consider when applying for our residency program.

California Medical License Information
New licensing requirements effective January 1, 2020 – updates provided on the UC Davis Graduate Medical Education website

Salary and Benefit Information
The UC Davis Health resident program human resources website provides current salary and benefits information

Life in Sacramento and Beyond
Sacramento is a culturally diverse city that offers many events and activities to foster a healthy work life balance


If you have questions about the application procedure, please email Tina Roberts, residency coordinator, at tcroberts@ucdavis.edu.

Thank you for your interest in the UC Davis Radiation Oncology Residency program.

The University of California, Davis is an equal opportunity/affirmative action employer with a strong institutional commitment to the achievement of diversity among its faculty, staff and students.